Pharmaceuticals and Biotech

Showing 1-10 of 21

29 Dec 2017  |  Global

Emerging Sensor Technologies Transforming Medical Diagnostics

The Optimal Synergy between Leading-edge Science and Medical Innovation

TechVisions latest research service profiles innovations in sensing technologies and their impact on clinical diagnosis. The emergence of point of care (PoC) testing has necessitated compact, more portable testing kits, to replace laboratory testing. In the light of global epidemic outbreaks, there is also a greater need for high throughput testing...

USD 4,950.00

USD 4,207.50 save 15 %

29 Dec 2017  |  North America

Innovations in Transdermal Drug Delivery

Microneedle Technologies Creating Novel Opportunities in Transdermal Drug Delivery Industry

With the healthcare industry moving toward patient convenience and comfort, pharmaceutical and medical device companies are continuously researching for the most effective, side effect free, convenient route of drug delivery. Transdermal drug delivery is a painless method of delivering drug formulation. Transdermal route of drug administration has ...

USD 4,950.00

USD 4,207.50 save 15 %

29 Dec 2017  |  Global

Antimicrobial Technologies for Enhanced Consumer Health

Novel Microbicidal Platforms Likely to Transform the Future of Global Consumer Health

Healthcare-associated infection (HAI) continues to be a significant global concern, hence there is growing research for developing new antimicrobial platforms that can significantly decrease the risk of microbial infections. While metallic ions continue to be one of the most potent antimicrobial technology platform, several new innovations across a...

USD 4,950.00

USD 4,207.50 save 15 %

09 Apr 2018  |  North America

Global Life Sciences Industry Outlook, 2018

Global Life Sciences Industry to Reach $1.5 T by 2022, Driven by Innovative Google, Amazon, Facebook, Apple (GAFA) Partnerships and R&D IT Investments

The global life sciences industry is onto a rocking start with the surge in CEO confidence from US tax reforms, rollicking equity markets and strengthening the global economy. Healthcare digitization, democratization creating explosion in patient data, emergence of value-based reimbursement models, and healthcare consumerism shifting the risk from ...

USD 4,950.00

USD 4,455.00 save 10 %

05 Jun 2018  |  Global

Anti-Aging Therapies and Services Market—Trends and Growth Opportunities, Forecast to 2022

Focus on Integrative Solutions Combining Dietary Supplements and Aesthetic Solutions with Clinical Therapeutics as the Market Moves Toward a ‘Prevent-Manage-Repair’ Continuum

The rapidly aging global population is placing immense pressure on healthcare systems across countries and regions. The improvement in life expectancy levels has created a large cohort of aged patients who suffer from one or more chronic diseases. Traditionally, the approach towards the management of this issue has been on ‘repair’, i.e., treat...

USD 4,950.00

USD 4,455.00 save 10 %

06 Jun 2018  |  Global

Cardiometabolic Diseases Market—Trends and Growth Opportunities, Forecast to 2022

Shift Towards a 'Comprehensive Care Continuum' with the Adoption of Integrated Care Pathways that Combine Clinical Therapies with Wellness Programs

Globally, cardiometabolic diseases are witnessing a consistent rise in prevalence every year, with hypertension and diabetes among the leading conditions. A rising population of hypertension is, in turn, leading to growing incidence of chronic heart failure with about 26 million cases of CHF globally. Although drug therapies are the first line of t...

USD 4,950.00

USD 4,455.00 save 10 %

29 Jun 2018  |  Global

Novel Therapies for Rare and Genetic Diseases

Unveiling One of the Most Promising Fields of Therapeutic Technology Synergy

Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...

USD 4,950.00

USD 4,455.00 save 10 %

04 Sep 2018  |  North America

Digital Transformation in the Pharmaceuticals Industry—Companies-to-Action, 2018

Value-based Care, Patient Data Digitization, and Collaborative Technology Deployment Offer Investment Opportunities

The pharmaceutical industry today is in a state of flux as it tries to maintain a delicate balance between the need for novel blockbuster drugs and the need for improved operational efficiencies in an increasingly competitive market space. As healthcare is becoming increasingly democratized, patients are emerging as key decision makers—digitally ...

USD 3,000.00

USD 2,700.00 save 10 %

24 Oct 2018  |  North America

Growth Opportunities in the Global Cell Therapy Market, Forecast to 2025

A Robust Product Pipeline Creating Opportunities for Ground-breaking Combination Therapies is Set to Revolutionize the Global Cell Therapy Market

The global pharmaceuticals industry is continuously evolving to meet the requirements of a changing disease landscape. With the increasing prevalence of chronic infectious diseases and cancer, market needs are shifting from traditional small molecules to novel large molecule therapies, with cell therapies dominating the space. This study presents a...

USD 4,950.00
30 Oct 2018  |  Africa

Healthcare Regulatory Environment in Kenya, Tanzania, and Ethiopia, 2018

Unlocking Investment Potential and Improving Healthcare Delivery and Access through Policy Advancement

The East African region boasts of a number of emerging leaders within Sub-Saharan Africa in terms of overall development and growth. On one hand, the region has one of the highest burdens of disease in the world, such as HIV, malaria, and tuberculosis. On the other hand, there has been a growing trend of non-communicable diseases, such as cancers a...

USD 1,500.00

Showing 1-10 of 21